TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24338990

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation radiotherapy
Number of subjects: 684

Group type: COMPARATOR
Intervention: Standard fractionation radiotherapy
Number of subjects: 684
Study: 23323673

Group type: EXPERIMENTAL
Intervention: 0.3 g kg(‐1) body mass sodium bicarbonate (NaHCO3)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0.1 g kg(‐1) body mass sodium chloride (placebo)
Number of subjects: 10
Study: 21632213

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 17468868

Group type: EXPERIMENTAL
Intervention: Fondaparinux 0.75 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fondaparinux 1.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fondaparinux 2.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fondaparinux 3.0 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16996845

Group type: EXPERIMENTAL
Intervention: Higher-rate pacing (80 pulses per minute)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Lower-rate pacing (60 pulses per minute)
Number of subjects: 49
Study: 14535871

Group type: EXPERIMENTAL
Intervention: 13C‐methacetin breath test (75 mg per os)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intra-operative 13C‐methacetin breath test
Number of subjects: 28
Study: 11085191

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (5 mg/kg/d of ZnSO4)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8930174

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Captopril and Quinapril
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 1403755

Group type: EXPERIMENTAL
Intervention: Deep tunnel scleral pocket incision
Number of subjects: 129

Group type: COMPARATOR
Intervention: Superficial scleral pocket incision
Number of subjects: 129
Study: 3325260

Group type: EXPERIMENTAL
Intervention: Ofloxacin 400 mg, twice daily for a mean duration of 8.77 days
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Ofloxacin 600 mg, twice daily for a mean duration of 8.77 days
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Ofloxacin 800 mg, twice daily for a mean duration of 8.77 days
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Ofloxacin (all dosages combined)
Number of subjects: 667
Study: 29444690

Group type: EXPERIMENTAL
Intervention: 100 mg NBMI
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 300 mg NBMI
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 27491778

Group type: EXPERIMENTAL
Intervention: Dark Chocolate (DC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 24445732

Group type: EXPERIMENTAL
Intervention: 6-monthly follow-up with the SFP program (group A)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Referral to primary care physician with a single SFP program visit at 24 months (group B)
Number of subjects: 102
Study: 22220935

Group type: EXPERIMENTAL
Intervention: Active MIRE
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham MIRE (placebo group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Warm packs (control group)
Number of subjects: 30
Study: 20526195

Group type: EXPERIMENTAL
Intervention: GHB at doses of 0.32 g/70 kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GHB at doses of 0.56 g/70 kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GHB at doses of 0.75 g/70 kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GHB at doses of 1.0 g/70 kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GHB at doses of 1.8 g/70 kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GHB at doses of 2.4 g/70 kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GHB at doses of 3.2 g/70 kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GHB at doses of 0.32-3.2 g/70 kg
Number of subjects: 10
Study: 18427285

Group type: EXPERIMENTAL
Intervention: Tetradecylthioacetic acid (TTA) 200 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tetradecylthioacetic acid (TTA) 600 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tetradecylthioacetic acid (TTA) 1000 mg
Number of subjects: 18
Study: 16751039

Group type: EXPERIMENTAL
Intervention: Corneal drying (eyelid taping to prevent blinking)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Blinking freely after corneal drying
Number of subjects: 17
Study: 12826549

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.1 mg (Group I)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Psoas compartment block with ropivacaine 0.475% 25 mL (Group II)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (Group I)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Psoas compartment block (Group II)
Number of subjects: 53
Study: 10073440

Group type: EXPERIMENTAL
Intervention: Hand dishwashing liquid 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hand dishwashing liquid 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dominant hand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-dominant hand
Number of subjects: 0
Study: 7578986

Group type: EXPERIMENTAL
Intervention: GM-CSF mouthwash (0.01, 0.1, 1.0 or 10 mcg/ml)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo mouthwash (0.1 percent albumin)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: GM-CSF mouthwash (various doses)
Number of subjects: 45
Study: 2197002

Group type: EXPERIMENTAL
Intervention: Propofol 6 mg.kg‐1.hr‐1 and nitrous oxide 50% in oxygen
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Propofol 9 mg.kg‐1.hr‐1 with 100% oxygen
Number of subjects: 30

Group type: COMPARATOR
Intervention: Thiopentone 4 mg.kg‐1 and nitrous oxide 50% in oxygen with enflurane 1%
Number of subjects: 30
Study: 439317

Group type: EXPERIMENTAL
Intervention: Ticarcillin plus gentamicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cephalothin sodium plus gentamicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ticarcillin plus cephalothin
Number of subjects: 0
Study: 31330198

Group type: EXPERIMENTAL
Intervention: 'at least 5 cm'
Number of subjects: 330

Group type: COMPARATOR
Intervention: 'approximately 5 cm'
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: 'hard and fast'
Number of subjects: 330

Group type: COMPARATOR
Intervention: 'at least 5 cm' vs 'approximately 5 cm'
Number of subjects: 330

Group type: COMPARATOR
Intervention: 'hard and fast' vs 'approximately 5 cm'
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: 'hard and fast' vs 'at least 5 cm'
Number of subjects: 330
Study: 28064172

Group type: EXPERIMENTAL
Intervention: Nutritional assessment and physical activity programme (including aerobic exercise and mixed strengthening, balance and coordination exercises)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Nutritional assessment and physical activity programme
Number of subjects: 172
Study: 25413567

Group type: EXPERIMENTAL
Intervention: Bed rest
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Re-ambulation period
Number of subjects: 11
Study: 23806096

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Vitamin C infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Simultaneous infusion of GLP-1 and Vitamin C
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normoglycemia recovery
Number of subjects: 15

Group type: COMPARATOR
Intervention: Hyperglycemia post hypoglycemia
Number of subjects: 15
Study: 21790620

Group type: EXPERIMENTAL
Intervention: Self-help book (cognitive behavioral therapy for insomnia)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Sleep hygiene advice
Number of subjects: 155
Study: 19193233

Group type: EXPERIMENTAL
Intervention: Stepped smoking cessation intervention based on a trans‐theoretical model of change
Number of subjects: 3024

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3024
Study: 16750808

Group type: EXPERIMENTAL
Intervention: Cobedding (experimental group)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Routine care in separate beds (control group)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 82
Study: 15319567

Group type: EXPERIMENTAL
Intervention: AC (doxorubicin and cyclophosphamide)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: CMF (cyclophosphamide, methotrexate, and 5-fluorouracil)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Overall QOL (FACT-B)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Overall QOL during the first 9 months after randomization
Number of subjects: 160

Group type: COMPARATOR
Intervention: Average QOL during treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: Rate of recovery to baseline levels of QOL 1 year after randomization
Number of subjects: 160
Study: 11488799

Group type: EXPERIMENTAL
Intervention: Antireflux surgery
Number of subjects: 312
Study: 9286887

Group type: EXPERIMENTAL
Intervention: 10 mg/kg rectal acetaminophen
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 20 mg/kg rectal acetaminophen
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 30 mg/kg rectal acetaminophen
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Recommended dose of 10-15 mg/kg rectal acetaminophen
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Initial dose recommendation
Number of subjects: 28
Study: 8323451

Group type: EXPERIMENTAL
Intervention: BDP 400 micrograms/day
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: BDP 800 micrograms/day
Number of subjects: 17

Group type: COMPARATOR
Intervention: Salbutamol 800 micrograms/day
Number of subjects: 17
Study: 3549010

Group type: EXPERIMENTAL
Intervention: 250 mg single oral dose of ciprofloxacin
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: 500 mg single oral dose of ciprofloxacin
Number of subjects: 271
Study: 26542332

Group type: EXPERIMENTAL
Intervention: 10 mg/day rosuvastatin
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 100 mg/day aspirin
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 27262225

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1197
Study: 24728623

Group type: EXPERIMENTAL
Intervention: Maximal treadmill test (MTT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Submaximal treadmill test (SMTT)
Number of subjects: 32
Study: 23523089

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 1135

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 1135

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1135

Group type: EXPERIMENTAL
Intervention: Both treatments (RT and Tamoxifen)
Number of subjects: 1135

Group type: EXPERIMENTAL
Intervention: Either adjuvant radiotherapy or tamoxifen
Number of subjects: 1135

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 1135
Study: 20434199

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS), 200 microg once daily
Number of subjects: 429
Study: 18836092

Group type: EXPERIMENTAL
Intervention: Multifactorial strategy of pain management (n = 107) including anesthesic patch, specified vaccines, child education, parental accompaniment, and distraction with soap bubbles
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Multifactorial strategy of pain management
Number of subjects: 239

Group type: COMPARATOR
Intervention: Usual pain management (n = 132)
Number of subjects: 239
Study: 16787957

Group type: EXPERIMENTAL
Intervention: Multifaceted primary care decision-support intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard practice)
Number of subjects: 0
Study: 12796608

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg daily
Number of subjects: 238

Group type: COMPARATOR
Intervention: Tamoxifen 40 mg daily
Number of subjects: 238
Study: 10695097

Group type: EXPERIMENTAL
Intervention: 400 mg nimesulide beta cyclodextrin
Number of subjects: 148

Group type: COMPARATOR
Intervention: 100 mg nimesulide
Number of subjects: 148
Study: 8561204

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 244

Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 244
Study: 1906726

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil, epirubicin and mitomycin C (FEM)
Number of subjects: 69

Group type: COMPARATOR
Intervention: epirubicin
Number of subjects: 69
Study: 7123498

Group type: EXPERIMENTAL
Intervention: 5% casein hydrolysate (Amigen)
Number of subjects: 85

Group type: COMPARATOR
Intervention: 5% dextrose (D10W)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Isocaloric 10% dextrose in water (D10W)
Number of subjects: 85
Study: 31367878

Group type: EXPERIMENTAL
Intervention: Chyme reinfusion
Number of subjects: 117
Study: 31054846

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg daily
Number of subjects: 17598

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17598
Study: 30309351

Group type: EXPERIMENTAL
Intervention: Continuous suture technique
Number of subjects: 77

Group type: COMPARATOR
Intervention: Interrupted suture technique
Number of subjects: 77
Study: 25921035

Group type: EXPERIMENTAL
Intervention: Step training for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual physical activity (control)
Number of subjects: 50
Study: 24947281

Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus salivarius CUL61, Lactobacillus paracasei CUL08, Bifidobacterium animalis subspecies lactis CUL34 and Bifidobacterium bifidum CUL20; total of 10^10 organisms/day)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 436
Study: 22480204

Group type: EXPERIMENTAL
Intervention: UP446 250 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: UP446 500 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (CMC capsule)
Number of subjects: 60
Study: 21084042

Group type: COMPARATOR
Intervention: FPNS 200 µg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: FPNS (100, 200, 400, and 800 µg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: FPNS
Number of subjects: 16
Study: 18059993

Group type: EXPERIMENTAL
Intervention: Augmented low Dye taping technique (ALD)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (untaped side)
Number of subjects: 22
Study: 16163986

Group type: EXPERIMENTAL
Intervention: New community nursing model of care
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard community nursing care
Number of subjects: 56
Study: 11935150

Group type: EXPERIMENTAL
Intervention: NN2211 (1.25, 5.0, 7.5, 10.0, 12.5 microg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 17217034

Group type: EXPERIMENTAL
Intervention: Health education program for cancer risk reduction
Number of subjects: 649
Study: 7745174

Group type: EXPERIMENTAL
Intervention: Breastfeeding information booklet (sent to 75 mothers)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (75 mothers)
Number of subjects: 150
Study: 2661178

Group type: EXPERIMENTAL
Intervention: Nifedipine (20mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diltiazem (60mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verapamil (80mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (two tablets)
Number of subjects: 0
Study: 31987565

Group type: EXPERIMENTAL
Intervention: Continuous shortwave diathermy (15 min of 40-60 W) with exercise
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham diathermy with exercise
Number of subjects: 50
Study: 29500615

Group type: EXPERIMENTAL
Intervention: PAX Good Behavior Game (PAX) intervention
Number of subjects: 0
Study: 27625308

Group type: EXPERIMENTAL
Intervention: Targeted print-based intervention providing personalized risk information regarding CRC screening.
Number of subjects: 574

Group type: COMPARATOR
Intervention: General information about CRC screening (Control group).
Number of subjects: 574
Study: 24944140

Group type: EXPERIMENTAL
Intervention: HTLEF group (EF < 50%)
Number of subjects: 82
Study: 22064877

Group type: EXPERIMENTAL
Intervention: Iron-fortified formula (mean, 12.7 mg/L)
Number of subjects: 473

Group type: COMPARATOR
Intervention: Low-iron formula (mean, 2.3 mg/L)
Number of subjects: 473
Study: 19818062

Group type: EXPERIMENTAL
Intervention: Trospium chloride ER 60 mg
Number of subjects: 1165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1165
Study: 18947289

Group type: COMPARATOR
Intervention: Conventional Utility/Weingart pliers
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: New Debonding Instrument
Number of subjects: 30
Study: 15764487

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 14754497

Group type: EXPERIMENTAL
Intervention: Albendazole for 7 days (400 mg/day)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Albendazole for 5 days (400 mg/day)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Albendazole for 3 days (400 mg/day)
Number of subjects: 168
Study: 11509075

Group type: EXPERIMENTAL
Intervention: Physical therapy for the affected side (1 hour, 3 times a week for 6 weeks) combined with mental practice (listening to an audiotape 2 times a week, plus additional home practice)
Number of subjects: 1
Study: 9433618

Group type: EXPERIMENTAL
Intervention: EDSP sampling with 1% cutoff
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: EDSP sampling with 2% cutoff
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: EDSP sampling with 5% cutoff
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Non-EDSP families
Number of subjects: 1000
Study: 8425995

Group type: EXPERIMENTAL
Intervention: Intermittent transdermal nitroglycerin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Continuous transdermal nitroglycerin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 12
Study: 3434740

Group type: EXPERIMENTAL
Intervention: Intravenous atropine 600 micrograms
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tracheal atropine 600 micrograms
Number of subjects: 40
Study: 10295521

Group type: EXPERIMENTAL
Intervention: Adjuvant systemic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life considerations
Number of subjects: 0
Study: 31369406

Group type: EXPERIMENTAL
Intervention: Visco-Trabeculotomy (VT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (Trab-MMC)
Number of subjects: 51
Study: 28131632

Group type: EXPERIMENTAL
Intervention: CD56-enriched donor cell infusion after post-transplantation cyclophosphamide (PTCy)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (20 patients without CD56-enriched donor cell infusion)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CD56-enriched donor cell infusion after PTCy
Number of subjects: 10
Study: 25373391

Group type: EXPERIMENTAL
Intervention: Minocycline 100 mg once a day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amitriptyline 25 mg once a day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23406489

Group type: EXPERIMENTAL
Intervention: 1 Day Acuvue Moist for Astigmatism (daily disposable toric soft lens)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Acuvue Oasys for Astigmatism (2-weekly replacement, re-usable toric soft lens)
Number of subjects: 200

Group type: COMPARATOR
Intervention: 1 Day Acuvue Moist for Astigmatism and Acuvue Oasys for Astigmatism
Number of subjects: 200
Study: 21829871

Group type: EXPERIMENTAL
Intervention: Body bath with neutral soap followed by natural drying of the umbilical cord
Number of subjects: 362

Group type: COMPARATOR
Intervention: Alcohol 70% at each diaper change until separation and bath two days later
Number of subjects: 362
Study: 19125978

Group type: EXPERIMENTAL
Intervention: ProRoot Endo Sealer
Number of subjects: 60

Group type: COMPARATOR
Intervention: AH Plus Jet
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pulp Canal Sealer
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (SBF immersion)
Number of subjects: 60
Study: 17722968

Group type: EXPERIMENTAL
Intervention: Oral bisphosphonates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous bisphosphonates
Number of subjects: 0
Study: 15559109

Group type: EXPERIMENTAL
Intervention: Endogenous cueing (valid and invalid cues)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Line motion illusion
Number of subjects: 0
Study: 11124758

Group type: EXPERIMENTAL
Intervention: 15 g D‐tagatose added to the diet daily
Number of subjects: 6
Study: 9628207

Group type: EXPERIMENTAL
Intervention: Qigong Yangsheng
Number of subjects: 30
Study: 7942652

Group type: EXPERIMENTAL
Intervention: Carbamide peroxide home bleaching agent for 72 hours before bonding
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Distilled water immersion for 1 week after bleaching for 72 hours
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (etched and bonded in the usual manner)
Number of subjects: 60
Study: 3069752

Group type: EXPERIMENTAL
Intervention: SR‐Nic (slow-release nicardipine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: P (placebo)
Number of subjects: 30
Study: 31223042

Group type: EXPERIMENTAL
Intervention: 19.5 mg LNG-IUS
Number of subjects: 1697
Study: 28264823

Group type: EXPERIMENTAL
Intervention: Women born between 1925 and 1929
Number of subjects: 202638

Group type: EXPERIMENTAL
Intervention: Women born between 1950 and 1955
Number of subjects: 202638

Group type: EXPERIMENTAL
Intervention: Younger birth cohorts (born between 1935 and 1955)
Number of subjects: 202638

Group type: EXPERIMENTAL
Intervention: Women born between 1925 and 1945
Number of subjects: 202638

Group type: EXPERIMENTAL
Intervention: Subsequent cohorts after 1945
Number of subjects: 202638

Group type: EXPERIMENTAL
Intervention: All cohorts
Number of subjects: 202638
Study: 26206385

Group type: EXPERIMENTAL
Intervention: Communication training for specialists (14 hours, with 2.5 hours focused on reply letters)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Untrained doctors
Number of subjects: 123